UK markets open in 7 hours 43 minutes

ORIC Pharmaceuticals, Inc. (ORIC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.89-0.19 (-2.09%)
At close: 04:00PM EDT
8.89 0.00 (0.00%)
After hours: 06:16PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-91,046
-100,697
-89,122
-78,715
-73,703
-
Depreciation & amortisation
948
1,032
966
897
970
-
Stock-based compensation
14,829
15,226
14,460
12,853
5,278
-
Change in working capital
-555
4,898
-445
4,073
2,045
-
Accounts payable
-
-
-
2,931
4,303
986
Other working capital
-78,278
-86,537
-77,221
-60,480
-45,935
-
Other non-cash items
-
-
-
-
19,843
-
Net cash provided by operating activities
-76,098
-85,688
-75,143
-59,541
-45,268
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,180
-849
-2,078
-939
-667
-
Purchases of investments
-243,252
-239,244
-238,124
-69,626
-225,485
-
Sales/maturities of investments
108,235
196,690
130,954
229,000
10,000
-
Other investing activities
-
-
-
-
193
-
Net cash used for investing activities
-137,197
-43,403
-109,248
158,435
-215,959
-
Cash flows from financing activities
Common stock issued
0
85,000
25,000
50,000
271,308
-
Other financing activities
-
-227
-399
-1,852
-21,237
-
Net cash used provided by (used for) financing activities
1,245
85,658
25,225
49,134
250,514
-
Net change in cash
-212,050
-43,433
-159,166
148,028
-10,713
-
Cash at beginning of period
241,594
67,308
226,474
78,446
89,159
-
Cash at end of period
29,544
23,875
67,308
226,474
78,446
-
Free cash flow
Operating cash flow
-76,098
-85,688
-75,143
-59,541
-45,268
-
Capital expenditure
-2,180
-849
-2,078
-939
-667
-
Free cash flow
-78,278
-86,537
-77,221
-60,480
-45,935
-